These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2569255)

  • 61. Age-related changes in monkey and rodent neurochemistry.
    Wenk GL
    Neurobiol Aging; 1993; 14(6):689-90. PubMed ID: 8295689
    [No Abstract]   [Full Text] [Related]  

  • 62. Hippocampus: selective concentration of lead in the normal rat brain.
    Fjerdingstad EJ; Danscher G; Fjerdingstad E
    Brain Res; 1974 Nov; 80(2):350-4. PubMed ID: 4422673
    [No Abstract]   [Full Text] [Related]  

  • 63. The Brain of the Archerfish
    Karoubi N; Segev R; Wullimann MF
    Front Neuroanat; 2016; 10():106. PubMed ID: 27891081
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Low level exposure to lead.
    Lee WR; Moore MR
    BMJ; 1990 Sep; 301(6751):504-6. PubMed ID: 2207414
    [No Abstract]   [Full Text] [Related]  

  • 65. Regional changes in [3H]-noradrenaline uptake, catecholamines and catecholamine synthetic and catabolic enzymes in rat brain following neonatal 6-hydroxydopamine treatment.
    Jonsson G; Sachs C
    Med Biol; 1976 Aug; 54(4):286-97. PubMed ID: 8670
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of chronic alcohol feeding on adrenergic and cholinergic neurotransmission mechanism.
    Baratti CM; Rubio MC; Perec CJ; Tiscornia OM
    Am J Gastroenterol; 1980 Jan; 73(1):21-7. PubMed ID: 6103671
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of lead exposure on rat brain catecholaminergic neurochemistry.
    Meredith PA; McIntosh MJ; Petty MA; Reid JL
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 89(2):215-9. PubMed ID: 2898999
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Biochemical mechanisms of neurotoxic lead activity].
    Baranowska-Bosiacka I; Chlubek D
    Postepy Biochem; 2006; 52(3):320-9. PubMed ID: 17201068
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel catecholaminergic systems. Overview.
    Goldstein DS
    Adv Pharmacol; 1998; 42():819-24. PubMed ID: 9328023
    [No Abstract]   [Full Text] [Related]  

  • 71. Enzymes of neurotransmitter metabolism as neuronal markers in the central nervous system.
    Gombos G; Aunis D
    Scand J Immunol Suppl; 1982; 9():317-38. PubMed ID: 6134337
    [No Abstract]   [Full Text] [Related]  

  • 72. Undernutrition and the development of brain neurotransmitter systems.
    Wiggins RC; Fuller G; Enna SJ
    Life Sci; 1984 Nov; 35(21):2085-94. PubMed ID: 6149444
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Action of lead on neurotransmission in rats.
    McIntosh MJ; Meredith PA; Moore MR; Goldberg A
    Xenobiotica; 1989 Jan; 19(1):101-13. PubMed ID: 2569255
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.